CNR Institutional Research Information System

FEDELE, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.725
NA - Nord America 1.194
EU - Europa 646
SA - Sud America 605
AF - Africa 55
OC - Oceania 9
Totale 5.234
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.152
US - Stati Uniti d'America 1.128
CN - Cina 623
BR - Brasile 486
VN - Vietnam 308
HK - Hong Kong 289
IT - Italia 178
FR - Francia 157
KR - Corea 113
NL - Olanda 102
IN - India 49
AR - Argentina 48
JP - Giappone 44
FI - Finlandia 41
DE - Germania 37
GB - Regno Unito 37
BD - Bangladesh 35
EC - Ecuador 26
MX - Messico 23
CA - Canada 20
PL - Polonia 18
CO - Colombia 17
RU - Federazione Russa 16
ZA - Sudafrica 16
IL - Israele 14
ID - Indonesia 13
PK - Pakistan 13
TR - Turchia 13
IQ - Iraq 11
EG - Egitto 10
AU - Australia 8
ES - Italia 7
MA - Marocco 7
PY - Paraguay 7
SA - Arabia Saudita 7
UA - Ucraina 7
VE - Venezuela 7
CL - Cile 6
PE - Perù 6
AZ - Azerbaigian 5
SE - Svezia 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
GR - Grecia 4
IE - Irlanda 4
JO - Giordania 4
KE - Kenya 4
NP - Nepal 4
PT - Portogallo 4
UZ - Uzbekistan 4
AT - Austria 3
BB - Barbados 3
CR - Costa Rica 3
DK - Danimarca 3
JM - Giamaica 3
LT - Lituania 3
LV - Lettonia 3
PH - Filippine 3
PS - Palestinian Territory 3
RO - Romania 3
SN - Senegal 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
PA - Panama 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CD - Congo 1
CG - Congo 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
IR - Iran 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.232
Salva come PNG Salva come JPEG
Città #
Singapore 674
Santa Clara 356
Hong Kong 286
Hefei 250
Beijing 146
San Jose 145
Lauterbourg 135
Seoul 111
Los Angeles 95
Ho Chi Minh City 93
Ashburn 83
Hanoi 74
Naples 64
São Paulo 53
Tokyo 27
Dallas 23
Helsinki 23
Buffalo 22
Da Nang 21
Marigliano 20
New York 20
Giugliano in Campania 15
Minamishinagawa 14
Bengaluru 13
Dhaka 13
Frankfurt am Main 12
Rio de Janeiro 12
Warsaw 12
Belo Horizonte 11
Haiphong 11
Brasília 10
Council Bluffs 10
Turku 10
Falkenstein 9
Orem 9
Quito 9
Seattle 9
Atlanta 8
Guayaquil 8
Lappeenranta 8
Ribeirão Preto 8
Biên Hòa 7
Hải Dương 7
Manchester 7
Montreal 7
Phoenix 7
Buenos Aires 6
Chennai 6
Düsseldorf 6
Johannesburg 6
Manaus 6
Sorocaba 6
Avellino 5
Baku 5
Boston 5
Campinas 5
Caxias do Sul 5
Curitiba 5
Houston 5
Nha Trang 5
Ninh Bình 5
Nuremberg 5
Paris 5
Quảng Ngãi 5
Quận Bình Thạnh 5
Salvador 5
Shanghai 5
Stockholm 5
Thái Bình 5
Afragola 4
Baghdad 4
Bari 4
Brooklyn 4
Chicago 4
Contagem 4
Dammam 4
Guarulhos 4
Islamabad 4
Istanbul 4
Karachi 4
Lima 4
London 4
Madrid 4
Milan 4
Piracicaba 4
Portsmouth 4
Rome 4
Sydney 4
São Gonçalo 4
Tashkent 4
The Dalles 4
Toledo 4
Amman 3
Asunción 3
Bogotá 3
Bình Dương 3
Bắc Giang 3
Bắc Ninh 3
Cape Town 3
Dakar 3
Totale 3.204
Salva come PNG Salva come JPEG
Nome #
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies 108
PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis. 89
HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. 87
Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-?B 80
Suppression of transformation by inhibition of HMGI-C protein synthesis: regulatory changes of NF-kB and AP-1 transcription factors. 79
Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product 78
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors 76
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 75
Altered MicroRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1 73
Optimization of Short RNA Aptamers for TNBC Cell Targeting 72
CBX7 gene expression plays a negative role in adipocyte cell growth and differentiation. 67
HMGA1 and HMGA protein expression in mouse speramatogenesis 66
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype 66
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells 64
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration 63
Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles 63
The role of the suppressor genes and of HMGI proteins. 62
The dosage of Patz1 modulates reprogramming process 61
Metabolic Reprogramming in Thyroid Cancer: Role of the Epithelial-Mesenchymal Transition 61
Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer 61
Mechanism of Action of Lactic Acid on Histones in Cancer 60
Profiling cancer cells by cell-selex: Use of aptamers for discovery of actionable biomarkers and therapeutic applications thereof 57
The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression 56
Subtype Transdifferenziation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression 55
Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities 55
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells 55
POZ-, AT-hook-, and Zinc Finger-containing Protein (PATZ) Interacts with Human Oncogene B Cell Lymphoma 6 (BCL6) and Is Required for Its Negative Autoregulation 53
Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice 52
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype 52
The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement 52
Aptamer-Based Strategies to Boost Immunotherapy in TNBC 52
AP-1 compositional changes in transformed thyroid cells: role of fra-1 induction and functional interaction with the HMGI-C gene product. 50
Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Ha-Ras(V12) Oncogene 50
PATZ1 is a new prognostic marker of diffuse large B cell lymphomas 50
Pituitary tumors: New insights into molecular features, diagnosis and therapeutic targeting 49
HMGA2 cooperates with either p27 deficiency or Cdk4 mutation in pituitary tumorigenesis. 49
The Transcription Regulator Patz1 Is Essential for Neural Stem Cell Maintenance and Proliferation 49
Aptamers and antibodies: rivals or allies in cancer targeted therapy? 49
AI identifies potent inducers of breast cancer stem cell differentiation based on adversarial learning from gene expression data 49
Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells. 48
PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas 47
PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells 47
Aptamer-mediated impairment of EGFR-integrin alpha v beta 3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers 46
PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context 46
Transcriptional and post-transcriptional regulation of transmembrane protein 132A 45
Epithelial–Mesenchymal Transition (EMT) 45
Binding to the Other Side: The AT-Hook DNA-Binding Domain Allows Nuclear Factors to Exploit the DNA Minor Groove 45
Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype 44
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. 44
Epithelial–Mesenchymal Transition (EMT) 2021 44
Embryonic defects and growth alteration in mice with homozygous disruption of the Patz1 gene. 43
Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications 43
Regulation of microRNA expression by HMGA1 proteins. 42
CBX7 is a tumor suppressor in mice and humans 42
Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells 42
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities 42
The high mobility group A2 gene is amplified and overexpressed in human prolactinomas 41
PATZ attenuates the RNF4-mediated enhancement of androgen receptor-dependent transcription. 41
Role of Diet in Stem and Cancer Stem Cells 41
Animal Models of Human Pathology 2020 40
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRbeta aptamer 40
Overexpression of the HMGA2 gene induces mixed growth hormone cell/prolactin cell pituitary adenomas by impairment of the RB/E2F pathway 39
Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein. 39
Loss of one or two PATZ1 alleles has a critical role in the progression of thyroid carcinomas induced by the RET/PTC1 oncogene 39
HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents 39
HMGA2 cooperates with either p27kip1 deficiency or Cdk4R24C mutation in pituitary tumorigenesis Cell Cycle 39
HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance 37
Animal models of human pathology 37
High mobility group A-interacting proteins in cancer: focus on chromobox protein homolog 7, homeodomain interacting protein kinase 2 and PATZ 36
Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis 35
Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. 34
Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. 33
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. 33
Proneural-mesenchymal transition: Phenotypic plasticity to acquire multitherapy resistance in glioblastoma 32
The Genetics of Pituitary Adenomas 31
The suppression of thyroid cell transformation by inhibition of HMGI-C protein synthesis is associated with changes in the AP-1 activity. 31
Identification and Characterization of a Novel RING-Finger Gene (RNF4) Mapping at 4p16.3 30
A mutated p53 gene alters thyroid cell differentiation. 29
Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. 29
The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas 29
A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth 28
HAND1 gene expression is negatively regulated by the high mobility group A1 proteins and is drastically reduced in human thyroid carcinomas 27
Regulation of thymosin b10 expression by TSH and other mitogenic signals in the thyroid gland and in cultured thyrocytes 27
A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression 27
Thyroid differentiation is blocked by a mutated p53 gene. 27
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas 27
Pituitary adenoma: Role of HMGA proteins 27
FRA-1 expression in hyperplastic and neoplastic thyroid diseases. 27
Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice 27
La trasformazione neoplastica di cellule tiroidee di ratto è associata a cambiamenti nell'attività del complesso trascrizionale AP-1. 26
Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression 26
Role of HMGI-Y proteins in adipogenesis. 26
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. 26
SOM230, a new somatostatin analog, is highly effective in the therapy of GH/PRL-secreting pituitary adenomas spontaneously developing in transgenic mice overexpressing the HMGA2 gene 26
High-Mobility-Group protein I(Y) as potential tumour marker in Human Colorectal Carcinomas. 26
High Mobility Group I proteins in adipocytic cell transformation. 25
Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein evels in sporadic breast carcinoma 25
Animal models of human pathology 2014 25
PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas 25
Roles of HMGA proteins in cancer. 25
Totale 4.579
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.691
article - articoli 13.746
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 465
Totale 30.902
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202493 0 0 0 0 0 0 0 0 23 0 30 40
2024/20252.054 30 12 140 68 335 89 87 110 126 148 476 433
2025/20263.299 163 475 315 528 584 172 477 160 164 163 98 0
Totale 5.446